GlaxoSmithKline PLC (NYSE:GSK)

39.44
Delayed Data
As of 1:21pm ET
 +0.049 / +0.12%
Today’s Change
36.41
Today|||52-Week Range
42.36
+3.22%
Year-to-Date
Merck's Keytruda Fails in Late-Stage Breast Cancer Study
9:26am / Zacks.comZAK - Paid Partner Content
Sphera Funds Management Ltd. Buys Johnson & Johnson, Novo Nordisk A/S, Bristol-Myers ...
May 15 / GuruFocus News - Paid Partner Content
Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site
May 17 / Zacks.comZAK - Paid Partner Content
Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates
May 08 / Zacks.com - Paid Partner Content
How to Invest in Biotech: Known Your Catalysts
May 16 / GuruFocus NewsGURU - Paid Partner Content
Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong
May 08 / Zacks.com - Paid Partner Content
Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK
May 16 / PR NewswirePRN - Paid Partner Content
What's in Store for Axsome (AXSM) This Earnings Season?
May 07 / Zacks.com - Paid Partner Content